Is Ketamine Therapy Safe? Side Effects, Risks, and What to Expect

"Is this safe?" It is the first question nearly every patient asks me, and it deserves a thorough, honest answer. As a board-certified physician who has supervised hundreds of ketamine therapy sessions, I want to give you the same candid information I share with my own patients.

The short answer: at the sub-anesthetic doses used for psychiatric treatment, ketamine has a well-established safety profile backed by decades of clinical use. But like any medical treatment, it comes with considerations you should understand before starting.

Understanding Sub-Anesthetic Dosing

Ketamine was FDA-approved as an anesthetic in 1970 and has been used safely in hospitals for over 50 years. The doses used for depression, anxiety, and PTSD treatment are a fraction of anesthetic doses -- typically 10-25% of what would be used in surgery.

At these lower doses, ketamine produces its therapeutic effects on mood and neuroplasticity while maintaining a wide safety margin. This is the same medication that pediatric emergency departments use regularly because of its favorable safety profile.

To understand how ketamine works at these doses, it primarily blocks NMDA glutamate receptors, triggering a cascade of neuroplastic changes that can rapidly improve mood and reduce anxiety.

Common Side Effects During Treatment

Most side effects occur during the session itself and resolve within 1-2 hours. Here is what patients typically experience:

Dissociation (very common): A feeling of detachment from your surroundings, sometimes described as "floating" or feeling "dreamlike." This is actually related to the therapeutic mechanism and is temporary. Most patients find it manageable, and many describe it as a positive or neutral experience. For a deeper look at the subjective experience, read our guide on what ketamine therapy feels like.

Nausea (common): Roughly 15-30% of patients experience mild nausea. This can usually be managed with anti-nausea medication taken beforehand, an empty stomach, and a comfortable position. It resolves as the medication wears off.

Elevated blood pressure (common): Ketamine can temporarily raise blood pressure by 15-25%. For healthy patients, this is clinically insignificant. For patients with uncontrolled hypertension, this is a contraindication we screen for during your initial consultation.

Dizziness and drowsiness (common): You may feel lightheaded or sleepy during and shortly after treatment. This is why we require a support person to be present and why you cannot drive for 24 hours after treatment.

Visual changes (less common): Some patients notice heightened colors, patterns, or blurred vision during the session. These resolve completely as the medication clears your system.

What About Serious Risks?

Serious adverse events with sub-anesthetic ketamine are rare but worth discussing:

Bladder issues: Long-term, frequent recreational ketamine use has been associated with bladder damage. However, at the therapeutic doses and treatment frequencies used in clinical practice (typically 2-3 sessions per month), this risk is extremely low. We monitor all patients for urinary symptoms.

Psychological distress: In rare cases, the dissociative experience can be unsettling, particularly for patients with a history of psychosis or active substance use disorders. This is why thorough screening is essential before beginning treatment.

Cardiovascular events: Extremely rare at sub-anesthetic doses, but possible in patients with severe, uncontrolled cardiovascular disease. This is screened during your evaluation.

Dependence potential: Ketamine is a Schedule III controlled substance. At therapeutic doses and supervised frequencies, the risk of dependence is very low. Our physician oversight model includes monitoring for any signs of misuse.

Who Should NOT Receive Ketamine Therapy

Not everyone is a candidate for ketamine therapy. Our eligibility screening identifies these contraindications:

• Active psychosis or schizophrenia -- ketamine can worsen psychotic symptoms
• Uncontrolled high blood pressure -- the temporary BP elevation could be dangerous
• Severe cardiovascular disease -- including recent heart attack or unstable angina
• Active substance use disorder -- particularly involving ketamine, PCP, or other dissociatives
• Pregnancy or breastfeeding -- insufficient safety data in this population
• Untreated hyperthyroidism -- can amplify cardiovascular effects

If you are unsure whether you are a candidate, the best approach is to complete our free eligibility assessment. It takes two minutes and gives you a clear answer.

How Physician Supervision Keeps You Safe

At Tovani Health, every patient's treatment is managed by me directly -- not a rotating panel of providers. Here is what that means for your safety:

Pre-treatment screening: Before prescribing ketamine, I review your complete medical history, current medications, and mental health background. This catches potential interactions and contraindications.

Personalized dosing: Your dose is calibrated to your body weight, medical history, and response. We start conservatively and adjust based on your experience.

Session support: During treatment, you have access to peer support, AI-powered guidance through our KetAI companion, and direct physician access if needed. Your support person provides an additional layer of safety.

Ongoing monitoring: I track your response across sessions, adjusting your treatment plan based on progress and any side effects you report. This is fundamentally different from a one-size-fits-all approach.

The Safety Comparison Most People Miss

When patients ask me about ketamine safety, I often ask them to consider the alternative: continued suffering from treatment-resistant depression, with all its associated risks -- including the well-documented risks of suicide, substance abuse, and physical health decline.

The medications many patients are already taking -- SSRIs, SNRIs, benzodiazepines -- all carry their own side effect profiles, some of which are more significant than ketamine's. The question is rarely "is this perfectly safe?" but rather "does the benefit outweigh the risk for my specific situation?"

For most patients who have failed two or more antidepressant trials, the answer is clear. The evidence base for ketamine in treatment-resistant depression shows response rates of 60-70%, with an onset measured in hours rather than weeks.

What to Do If You Experience Side Effects

Most side effects need no intervention beyond patience -- they resolve on their own within 1-2 hours. However, contact your care team if you experience:

• Severe or persistent nausea beyond the session
• Chest pain or heart palpitations
• Prolonged dissociation lasting more than 3 hours
• Urinary symptoms (pain, frequency, blood)
• Persistent anxiety or mood changes between sessions

These situations are uncommon but important to address promptly. Having a direct line to your prescribing physician -- rather than a generic support line -- makes a significant difference.

Making an Informed Decision

Informed consent means understanding both the potential benefits and the real risks. I have tried to present both honestly here, without either minimizing the risks or overstating them.

If you are considering ketamine therapy, the next step is a straightforward eligibility check that takes two minutes. It will tell you whether you are a candidate based on your medical history, and if you are, we will have a thorough conversation about what treatment looks like for your specific situation.

You can also explore our ketamine safety protocols page or learn about what to expect during treatment for additional detail.

Your safety is not just a priority -- it is the foundation everything else is built on. That is why every Tovani Health patient receives direct care from a board-certified physician who knows their history and takes responsibility for their outcome.

Check your eligibility today -- it is free, takes two minutes, and there is no obligation.